Source: BioPortfolio

Metabiologics: Object Pharma Announces Strategic Acquisition of Metabiologics

Object Will Commercialize the Full Spectrum of Botulinum Neurotoxins to Address Unmet Needs in Aesthetic and Therapeutic MarketsNEWPORT BEACH Calif. PRWEB May 30 2019 Object Pharma Inc. a startup company innovating the future of neurotoxins is pleased to ...

Read full article »
Metabiologics's Competitors | Metabiologics's News | Metabiologics's Financials
Stay up-to-date with the latest news on Metabiologics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Aaron Chamberlain's photo - President of Metabiologics

President

Aaron Chamberlain

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Metabiologics